Search

Author/Creator Schmidt, Elvira

1. 1190. Burden of Congenital Cytomegalovirus Among Newborns/Infants < 2 Years of Age From 2010 to 2020. (4th December 2021)

Authors:
Fowler, Karen; Mucha, Jacek; Monika, Neumann; Lewandowski, Witold; Kaczanowska, Magdalena; Schmidt, Elvira; Natenshon, Andrew; Talarico, Carla; Buck, Philip; Diaz-Decaro, John D
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S686
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1390. Effectiveness of M-M-R® II in outbreaks - a systematic literature review of real-world observational studies. (31st December 2020)

Authors:
Li, Se; Kuter, Barbara J; Schmidt, Elvira; Richardson, Elizabeth; Saldutti, Louise P; Monika, Neumann; Koller, Linnea; Agrawal, Manica; Pawaskar, Manjiri D
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S704
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. (2nd December 2019)

Authors:
Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C.
Journal:
Current medical research and opinion
Issue:
Volume 35:Number 12(2019)
Page Start:
2079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079–2087. (2nd July 2020)

Authors:
Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C.
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 7(2020)
Page Start:
1129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Use of M-M-R II outside of the routinely recommended age range – a systematic literature review. Issue 1 (31st December 2022)

Authors:
Pawaskar, Manjiri; Schmidt, Elvira; Marshall, Gary S.; Fergie, Jaime; Richardson, Elizabeth; Saldutti, Louise Parks; Li, Se; Neumann, Monika; Koller, Linnea; Kuter, Barbara
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Use of M-M-R II outside of the routinely recommended age range – a systematic literature review. Issue 1 (31st January 2022)

Authors:
Pawaskar, Manjiri; Schmidt, Elvira; Marshall, Gary S.; Fergie, Jaime; Richardson, Elizabeth; Saldutti, Louise Parks; Li, Se; Neumann, Monika; Koller, Linnea; Kuter, Barbara
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 18:Issue 1(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗